For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Goodfellow Gems #157
Wednesday 29 September 2021, 12:42 AM

“Long COVID in patients who were not hospitalised”
A study of an Arizona cohort of 3030 non-hospitalised patients with COVID-19 found that while some patients recover quickly, persistent symptoms are n
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
bit.ly/2X6kA9b (PLoS One 2021;16[8]:e0254347).